| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/20/2001 | CN1300286A Crystalline form of paroxetine |
| 06/20/2001 | CN1300285A Oxyiminoalkanoic acid derivatives |
| 06/20/2001 | CN1300282A Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 06/20/2001 | CN1300281A Compounds with growth hormone releasing properties |
| 06/20/2001 | CN1300280A Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 06/20/2001 | CN1300279A Modulators of protein tyrosine phosphatases |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/20/2001 | CN1300226A Dextrin-containing composition for preventing surgical adhesions |
| 06/20/2001 | CN1300224A Protease inhibitors in absorbent articles |
| 06/20/2001 | CN1300223A Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 06/20/2001 | CN1300221A Treatment of cardiao hypertrophy |
| 06/20/2001 | CN1300219A Epiallopregnanolone in the treatment of CNS disorders |
| 06/20/2001 | CN1300218A Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 06/20/2001 | CN1300217A New drug combinations of A N.A.R.I., preferably reboxetine, and pindolol |
| 06/20/2001 | CN1300216A Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts of hydrates |
| 06/20/2001 | CN1300214A Composition comprising acarnitine and glutathione, useful to incrense the absorption of glutathione and synergize its effects |
| 06/20/2001 | CN1300213A Gamma-contained aminobutyric acid derivatives solid compositions and preparation process thereof |
| 06/20/2001 | CN1300212A Novel fatty analogues for the treatment of obesity, hypertension and fatty liver |
| 06/20/2001 | CN1300211A Novel fatty analogues for the treatment of premary and secondary restenosis |
| 06/20/2001 | CN1300210A Hydroxamic acid derivatives as antibacterials |
| 06/20/2001 | CN1300209A Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage |
| 06/20/2001 | CN1300191A Nutritional product for a person having renal failure |
| 06/20/2001 | CN1300189A Products containing polyphenol(S) and L-arginine to stimulate nitric oxide production |
| 06/20/2001 | CN1300186A Bactericides |
| 06/20/2001 | CN1299834A Ginkgo Testa Polysaccharide and the preparation of pharmaceutical thereof |
| 06/20/2001 | CN1299818A Tea flavone as one flavone compound from tea |
| 06/20/2001 | CN1299813A N-substituted benzyl or phenyl aromatic amide compound and its use |
| 06/20/2001 | CN1299676A Fatigue relieving medicine for driver |
| 06/20/2001 | CN1299648A Hydrolytic nucleic acid solution |
| 06/20/2001 | CN1299647A Delayed praziquantel bar for dog |
| 06/20/2001 | CN1299646A Application of venoruton in treating cataract |
| 06/20/2001 | CN1067410C Improved preparation method for biodegradable polymeric microspheres using solvent extraction and preparation method for microspheres for treating local inflammation using same |
| 06/20/2001 | CN1067405C Indocalamus-leaf polyose sulfate and preparation process therefor |
| 06/20/2001 | CN1067401C 5-0-deosaminyl 6-0-methyl erythronolide A derivatives and preparation method therefor |
| 06/20/2001 | CN1067393C Novel pyrimido [1,2-alpha] indoles |
| 06/20/2001 | CN1067392C Stable crystalline tetrahydrofolic acid salts |
| 06/20/2001 | CN1067391C Piperidyl methyl oxazolidinone |
| 06/20/2001 | CN1067389C Benzodihydropyran assorbic acid derivatives, their preparation and use |
| 06/20/2001 | CN1067387C 1,2,3,4-tetrahydroquinoxalindione derivative |
| 06/20/2001 | CN1067386C 5-heteroarylindole derivatives as benzodiazepine receptor site agnoists and analagonists |
| 06/20/2001 | CN1067385C Novel substituted piperidines useful for the treatment of allergic diseases |
| 06/20/2001 | CN1067384C Adhesion receptor antagonists, its preparation method and use as farm chemicals |
| 06/20/2001 | CN1067381C New 4-imidazolidinone compound, process for its preparation and pharmaceutical compositions which contain it |
| 06/20/2001 | CN1067378C N,N-diethyl-8,8-dipropyl-2-azaspiro(4.5)decane-2-propananine dimaleate |
| 06/20/2001 | CN1067252C Cosmetics or pharmaceutical composition and use of antioxidation system in said composition |
| 06/20/2001 | CN1067247C Use of sodium alginate diester in medicine for preventing and curing thrombocytopenia and leukopenia |
| 06/20/2001 | CN1067246C Application of N-aceto-D-aminoglucose for preparing skin sanitary article preparation |
| 06/20/2001 | CN1067245C Application of N-aceto-D-aminoglucosein medicinal preparation for cuing respiratory tract diseases |
| 06/20/2001 | CN1067244C Notoginsenoside powder injection |
| 06/20/2001 | CN1067243C Medicinal Preparation for curing angiocardiopath |
| 06/20/2001 | CN1067242C Production of beta-form thiamine hydrochloride crystals and tablets made from same |
| 06/20/2001 | CN1067241C Method for producing injection used for curing fowls and animals dysentery and diarrhea |
| 06/19/2001 | USRE37234 Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
| 06/19/2001 | US6248909 Triglyceride and composition comprising the same |
| 06/19/2001 | US6248907 Alpha 1 and alpha 2 adrenoceptor antagonistic effects and urogenital selectivity; benign prostate hyperplasia; dibenzoyltartrate salt |
| 06/19/2001 | US6248905 Oil-solubility; easily permeate into living tissues to release l-ascorbic acid, resulting in an exertion of the physiological action inherent to l-ascorbic acid. |
| 06/19/2001 | US6248903 Process for the preparation of methyl (2s)-2-[(3r)-3-(n-{tert-butyloxycarbonyl 9-amino)-2-oxopyrrolidin-1-yl]propionate |
| 06/19/2001 | US6248901 Heterocyclic vinyl ethers |
| 06/19/2001 | US6248897 From beta-methyl l-aspartate |
| 06/19/2001 | US6248895 Benzofuroxan compound, method of preparation, pharmaceutical composition and method of treatment using the same |
| 06/19/2001 | US6248894 Fungicides for the control of take-all disease of plants |
| 06/19/2001 | US6248888 Heating 2-chloro-4-amino-6,7-dimethoxyquinazoline and 1-(2-tetrahydrofuroyl)piperazine in a polar organic reaction solution |
| 06/19/2001 | US6248882 Via dioxolane intermediates |
| 06/19/2001 | US6248841 Using 2-mercaptoethanol |
| 06/19/2001 | US6248791 Stimulating the differentiation of preadipocytic cells and therapies based thereon |
| 06/19/2001 | US6248790 Treatment of inflammation with 2,4,6-trihydroxy-alpha-rho-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives |
| 06/19/2001 | US6248789 Administration of ketamine to manage pain and to reduce drug dependency |
| 06/19/2001 | US6248788 Nervous system pain |
| 06/19/2001 | US6248787 Reducing cachexia |
| 06/19/2001 | US6248786 Sexual disorders |
| 06/19/2001 | US6248785 IL-8 receptor antagonists |
| 06/19/2001 | US6248784 Infant formula and methods of improving infant stool patterns |
| 06/19/2001 | US6248783 Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
| 06/19/2001 | US6248782 Method of treating viral diseases |
| 06/19/2001 | US6248780 Therapy for breast cancer |
| 06/19/2001 | US6248779 Synergistic mixture of vitamin e and squalane |
| 06/19/2001 | US6248778 Liver disorders |
| 06/19/2001 | US6248776 Anti-first-pass effect compounds |
| 06/19/2001 | US6248775 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 06/19/2001 | US6248774 Method for treating hyper-excited sensory nerve functions in humans |
| 06/19/2001 | US6248773 Vision defects |
| 06/19/2001 | US6248771 Formulations for hydrophobic pharmaceutical agents |
| 06/19/2001 | US6248765 Imidazole derivatives as histamine receptor H3 (ANT) agonists |
| 06/19/2001 | US6248763 Psoriasis |
| 06/19/2001 | US6248762 Microbicides |
| 06/19/2001 | US6248760 Tablet giving rapid release of nicotine for transmucosal administration |
| 06/19/2001 | US6248759 Administering a dihydropyridine calcium antagonist |
| 06/19/2001 | US6248758 Pharmaceutical antacid |
| 06/19/2001 | US6248757 Antiserotonine agents |
| 06/19/2001 | US6248755 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 06/19/2001 | US6248754 Psychological disorders |
| 06/19/2001 | US6248753 Bicyclic compounds |
| 06/19/2001 | US6248752 Azabicyclooctane compositions and methods for enhancing chemotherapy |
| 06/19/2001 | US6248751 Inhibition of hair growth |
| 06/19/2001 | US6248749 Use of inhibitors of the activity of retinoic acid for treating sensit ive skin and/or acute damage induced by UV radiation |
| 06/19/2001 | US6248747 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
| 06/19/2001 | US6248746 Phosphodiesterase (pde-iv) inhibitor for treatment of asthma, allergies, atopic diseases and rhinitis |
| 06/19/2001 | US6248745 Mixture comprising a cyclooxygenase-2 (cox-2) inhibitor and a 1,2-dihydro-4-aminoquinazoline derivative inhibitor of induced nitric oxide synthase (inos); non-steroidal antiinflammatory agents |
| 06/19/2001 | US6248744 Administering an analgesic dosage of an aminoalkenyl(pyridine or pyrimidine) derivative to relieve pain of menstruation, ovulation, pregnancy, childbirth, cancer, bone disorders, or injuries |